March 26, 2026
TOPLINE: Patients who received eye injections of anti-VEGF agents around the time of a stroke or myocardial infarction did not have an increased risk for mortality […]
March 26, 2026
March 26 (Reuters) – Kodiak Sciences’ experimental drug met the main goal in a late-stage study in patients with diabetes-related eye damage. Kodiak was testing the […]
March 23, 2026
Patients who present to their primary care providers experiencing new-onset or multiple floaters in their vision could be at risk for retinal tears or detachment and […]
March 23, 2026
TOPLINE: Patients with open globe eye injuries related to falls frequently had new or worsening medical problems or recent changes in medication around the time of […]
March 17, 2026
March 17 (Reuters) – The U.S. Food and Drug Administration declined to approve Aldeyra Therapeutics’ drug for a type of eye disease, the company said on […]
March 17, 2026
TOPLINE: People who received outpatient vision rehabilitation and had hearing impairment were older and in poorer physical health than those with normal hearing. They were also […]
March 16, 2026
Screening for glaucoma and estimating risk could get much more precise with advances underway in genomics and AI. These advances are helping experts understand the many […]
March 12, 2026
TOPLINE: Over 24 months, patients with dry age‑related macular degeneration (AMD) who received light therapy with three wavelengths gained clarity of vision, had a reduced incidence […]
March 9, 2026
TOPLINE: In patients with glaucoma, preoperative use of the alpha-agonist brimonidine is associated with a nearly threefold increased risk for trabeculectomy failure due to elevated intraocular […]